期刊文献+

人促甲状腺激素受体全长表达载体在真核细胞内的稳定表达 被引量:1

Stable expression of pcDNA3.1-hTSHR in CHO cells
下载PDF
导出
摘要 目的构建pcDNA3.1/人TSH受体(human thyroid-stimulating hormone receptor,hTSHR)基因真核表达载体(已完成),将该真核表达载体在CHO细胞(中国仓鼠卵巢细胞)中表达,并筛选获得稳定表达细胞株。方法通过脂质体介导,用重组质粒pcDNA3.1-hTSHR转染CHO细胞,以G 418筛选稳定表达细胞株,挑取单克隆,扩大培养并传代;取P5代细胞,抽提基因组DNA及蛋白分别用PCR及Western blot方法鉴定被转染CHO细胞hTSHR的表达情况。结果得到阳性单克隆5个,传代培养。P5代细胞PCR扩增产物为约530 bp特异性条带,大小与预期相符,未见非特异性条带。Western印记法结果表明被转染CHO传代细胞有hTSHR蛋白表达。结论pcDNA3.1-hTSHR真核表达载体可以在CHO细胞中稳定表达,成功构建稳定表达细胞株。为测定自身免疫性甲状腺疾病患者血清TSHR奠定了基础。 Objective To construct the recombinant eukaryotic expression vector with full length cDNA sequence of pcDNA3, 1/human thyroid-stimulating hormone receptor (hTSHR) (accomplished) and to express it in CHO cells (Chinese hamster ovary cells), then screen the stable expression cell lines. Methods Constructed pcDNA3. 1-hTSHR was transferred into CHO cells by liposome. The stable expression cell lines were screened by using G 418 and were cultured for generations. The fifth generation was selected and DNA and protein expressions of hTSHR in transferred CHO cells were detected by PCR and Western blot. Results Five monoclones with full length sequence of hTSHR gene were obtained. One band of approximately 530 bp in size was amplified by PCR which agreed with anticipation. Western blot confirmed that the expressed recombinant hTSHR protein was present and active in CHO cells. Conclusion The stable hTSHR expression cell lines has been successfully constructed, which would contribute to further studies on the TSHR function in the blood of patients with autoimmune thyroid disease.
出处 《同济大学学报(医学版)》 CAS 2009年第3期14-17,共4页 Journal of Tongji University(Medical Science)
基金 国家自然科学基金资助项目(30470819)
关键词 TSH受体 真核表达载体 CHO细胞 转染 稳定表达 TSHR eukaryotic expression vector CHO cell transfection stable expression
  • 相关文献

参考文献9

  • 1Brand OJ,Barrett JC,Simmonds MJ,et al.Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease (GD)[J].Hum Mol Genet,2009:25.
  • 2Ando T,Latif R,Davies TF.Thyrotropin receptor antibodies:new insights into their actions and clinical relevance[J].Best Pract Res Clin Endocrinol Metab,2005,19:33-52.
  • 3李晓永,冯绮文,董艳,周亚芹,葛勤敏,张洪梅,苏青.人甲状腺刺激激素受体cDNA的克隆及真核表达载体的构建[J].新乡医学院学报,2008,25(1):1-4. 被引量:3
  • 4Chen CR,et al.The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim[J].J Clin Invest,2003,111:1897-1904.
  • 5Kohn LD,Harii N.Thyrotropin receptor autoantibodies (TSHRAbs):epitopes,origins and clinical significance[J].Autoimmunity,2003,36:331-337.
  • 6Prabhakar BS,Bahn RS,Smith TJ.Current perspective on the pathogenesis of Graves' disease and ophthalmopathy[J].Endocr Rev,2003,24:802-835.
  • 7Morgenthaler NG,Nagata A,Katayama S,et al.Detection of low titre TBII in patients with Graves' disease using recombinant human TSH receptor[J].Clin Endocrinl,2002,57:193-198.
  • 8Morgenthaler NG,Ho SC,Minich WB.Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration,TSH receptor affinity,and binding sites[J].J Clin Endocrinol Metab,2007,92:1058-1065.
  • 9Massart C,Gibassier J,Verite F,et al.Use of Chinese hamster ovary cell lines transfected with cloned human thyrotropin receptor for the measurement of thyroid-stimulating antibodies:advantages and difficulties[J].Clin Chim Acta,2000,291:67-81.

二级参考文献10

  • 1葛勤敏,苏青.促甲状腺激素受体的裂解和脱落[J].上海交通大学学报(医学版),2007,27(3):354-356. 被引量:2
  • 2葛勤敏 苏青.促甲状腺激素受体抗体及其临床意义.上海交通大学学报:医学版,2006,26:1-5.
  • 3Rapoport B,Chazenbalk GD,Jaume JC,et al.The thyrotropin (TSH) receptor:interaction with TSH and autoantibodies[J].Endocr Rev,1998,19(6):673-716.
  • 4Kohn LD,Harii N.Thyrotropin receptor autoantibodies(TSHRAbs):epitopes,origins and clinical significance[J].Autoimmunity,2003,36(6-7):331-337.
  • 5Prabhakar BS,Bahn RS,Smith TJ.Current perspective on the pathogenesis of Graves disease and ophthalmopathy[J].Endocr Rev,2003,24(6):802-835.
  • 6Morgenthaler NG,Nagata A,Katayama S,et al.Detection of low titre TBII in patients with Graves' disease using recombinant human TSH receptor[J].Clin Endocrinl,2002,57(2):193-198.
  • 7McKenzie JM.Delayed thyroid response to serum from thyrotoxic patients[J].Endocrinology,1958,63(6):865-868.
  • 8Ludgate M,Perret J,Parmentier M,et al.Use of the recombinant human thyrotropin receptor (TSH-R) expressed in mammalian cell lines to assay TSH-R autoantibodies[J].Mol Cell Endocrinol,1990,73(1):R13-R18.
  • 9Perret J,Ludgate M,Libert F,et al.Stable expression of the human TSH receptor in CHO cells and characterization of differentially expressing clones[J].Biochem Biophys Res Commun,1990,171(3):1044-1050.
  • 10Massart C,Gibassier J,Verite F,et al.Use of Chinese hamster ovary cell lines transfected with cloned human thyrotropin receptor for the measurement of thyroid-stimulating antibodies:advantages and difficulties[J].Clin Chim Acta,2000,291(1):67-81.

共引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部